Oncology Information Systems Market Size, Share & Analysis Report, 2024-2033
The global oncology information systems market size was estimated at USD 8.45 billion in 2023 and is projected to hit around USD 17.75 billion by 2033, growing at a CAGR of 7.7% during the forecast period from 2024 to 2033.
Key Takeaways:
Oncology Information Systems Market Growth
Monumental growth of healthcare IT, the increasing global prevalence of cancer, increasing expenditure in development around treatments & solutions for cancer care, and increasing adoption of OIS solutions by healthcare facilities, are some of the key factors anticipated to drive the growth of the market. According to percancer.org, more than 1.9 million new cases of cancer were diagnosed in 2021, in the U.S. alone. A wide range of novel technologies is being developed, which have the potential to overhaul the treatment regime completely.
The OIS not only helps healthcare settings like hospitals, clinics, and research laboratories to manage and optimize cancer care solutions but also in the exchange of patient information across organizations to optimize treatment to improve patient safety and personalize treatments for patients for the best possible outcomes. Governments have been increasing their investments in research and development around oncology thus propelling the growth of the market. The National Cancer Institute received its budget from the United States Congress during the annual federal budgeting process, for the year 2022, the total amount was $6.9 billion, a $353 million increase from 2021.
Growing demand for OIS for streamlining patient information and data management has increased the demand for various kinds of OIS software. An increase in investments in cancer research by companies is forecasted to drive market growth. The market is expected to witness considerable growth in the near future and the companies are increasingly investing in the development of innovative and technologically advanced products. The investments by major players in the OIS development are going to be a massive opportunity due to a huge influx of funding and budgets for the healthcare sector, especially in the field of cancer. In the U.K., the government plans on spending $26 billion on research and development by 2024-2025.
USD 123.5 million have been allocated to the Office for Life Sciences for the government’s Life Sciences Vision and cancer research. Such initiatives coupled with new product and software launches by different companies are expected to fuel the market growth. The introduction of blockchain technology and Artificial Intelligence has eliminated the use of paper-based treatments, patient records, etc., and has made the management of patient data easy for both caregiver and patient. Moreover, AI in oncology is one of the factors driving the growth of the market. Systems and software generate high demands in the end-use facilities as they are mostly used by pharmaceutical companies and hospitals.
In addition, the key players are introducing new products in the same but with limited innovations. Hence, investment in R&D to develop products having more features might be beneficial for the companies. For instance, in 2020, Varian Medical Systems, Inc. announced an investment of around USD 10.0 million and a strategic collaboration agreement with COTA, Inc., a curator of clinical data in the oncology sector. Both the companies aim toward empowering cancer clinics with decision support tools, data analytics, operational decisions, and much more.OIS helps in efficiently managing the treatment schedules, treatment delivery, and plans, and further aid in promoting the information flow between the Radiation Therapy (RT) departments and the healthcare companies.
OIS also ensures that clinicians are providing treatment plans with the right procedures to the right patient, with the right cancer site, thereby guaranteeing an effective treatment by providing complete information about RT and the treatment results to clinicians whenever needed for the evaluation process and to enhance the treatment quality. Moreover, the demand for treatment planning systems will witness growth in the future owing to its advantages, such as storing large amounts of data and retrieving information as and when needed as well as helping doctors in scheduling the treatment of various patients. Companies, such as Varian Medical Systems, Elekta AB, and Accuray Inc., are a few big players operating in the market.
Oncology Information Systems Market Report Scope
| Report Attribute | Details |
| Market Size in 2024 | USD 9.11 Billion |
| Market Size by 2033 |
USD 17.75 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 7.7% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Product & services, application, end-user, region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | Elekta AB; Accuray Inc.; Varian Medical Systems; RaySearch Laboratories; Cerner Corp.; BrainLab; Philips Healthcare; Prowess, Inc.; DOSIsoft S.A.; ViewRay Inc.; MIM Software and Flatiron, McKesson Corporation, Siemens Medical Solutions Inc. |
Segments Insights:
Products & Services Insights
On the basis of products & services, the global market has been bifurcated into solutions and professional services. In 2023, the solutions segment accounted for the largest share of 74.16% of the global revenue. The segment is also anticipated to register the fastest growth rate of 8.2% during the forecast period. This segment is dominating the market owing to the rising adoption by healthcare providers for the proper management of radiology imaging. These solutions help in capturing cancer patient-reported outcomes and facilitates direct communication with patients and doctors, leading to the growth of this segment.
The segment growth can be further attributed to the development of more advanced OIS Solutions, which aids in better patient data management and improves cancer treatment. The solutions segment is further divided into patient information systems and treatment planning systems, wherein the treatment planning systems segment accounted for the largest share of the market in 2021. However, professional services are being increasingly accepted as most hospitals and clinics are outsourcing OIS services due to the lack of skilled professionals in hospitals and clinics. These services provide online consultation and customized schedules & reports, which, in turn, aid in improving the quality of care.
Application Insights
On the basis of applications, the global market has been further segmented into medical oncology, radiation oncology, and surgical oncology. The medical oncology segment accounted for the largest share of 63.5% of the global revenue in 2023. The medical oncology segment is further expected to grow at the fastest CAGR of 8.3% over the forecast period owing to the rapid advancements in immunotherapy, hormonal therapy, and targeted therapy for effectively treating various cancers. Moreover, several initiatives pertaining to cancer research are being undertaken by major players, which is further positively influencing the growth of the market.
The surgical oncology segment is also expected to witness significant growth during the forecast years. Cancer care has evolved rapidly over the decades. Surgery is no longer the treatment for most solid malignancies, but the combination of surgery and multi-modal therapies mostly focused on radiotherapy, targeted molecular therapies, and chemotherapy is the preferred treatment. Some procedures, such as cytoreductive surgery, isolated limb perfusion, laparoscopic cancer surgery, and sarcoma surgery can be performed in highly specialized healthcare centers. Thus, increasing complexity in surgical treatments for solid malignancies is expected to drive the growth of the market.
Regional Insights
The North America regional market accounted for the largest revenue share of 40.9% in 2023. Key factors responsible for this growth include the presence of sophisticated healthcare infrastructure and increasing awareness about patient information management in the region. Moreover, the growing adoption of OIS to track and record treatment results of cancer patients and the rising importance of EMR for making better treatment decisions are expected to boost the regional market growth. The rising need for treatment schedules management, dose management, and treatment planning is also expected to increase the demand for OIS in this region.
In addition, the strong presence of several global players in the region, such as Accuray Inc. Cerner Corp., Varian Medical Systems, Inc., McKesson Corp., and Epic Systems Corp., supports the market growth. Asia Pacific is anticipated to register the fastest growth rate of 8.9%. However, Asian countries are witnessing high demand for OIS and are gradually developing due to the supportive government policies and increasing awareness about the benefits of these systems. This region may serve as a hot revenue pocket for players wishing to tap the potential of this region. Therefore, players wishing to capture a large share in this market must design specific pricing policies and also marketing strategies developed specifically for this region that will help them gain a foothold in these lucrative markets.
Key Companies & Market Share Insights
Key companies are primarily focused on incorporating technological innovation with the introduction of web-based oncology solutions and Artificial Intelligence (AI)-based OIS solutions with a goal to enhance the treatment regime, thereby expected to positively impact the market growth in the near future. Some of the key market players operating in the global oncology information systems market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the Oncology Information Systems market.
By Product
By Application
By End User
By Region
Chapter 1 Oncology Information Systems Market: Research Methodology & Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database:
1.3.1.2 nova one advisor internal database
1.3.2 Primary Research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Oncology Information Systems Market: Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Global Oncology Information Systems Snapshot
Chapter 3 Oncology Information Systems Market: Variables, Trends, & Scope
3.1 Market Segmentation
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.3.3 Industry Challenges
3.4 Global Oncology Information Systems Market Analysis Tools
3.4.1 Industry Analysis - Porter’s
3.4.1.1 Bargaining power of the suppliers
3.4.1.2 Bargaining power of the buyers
3.4.1.3 Threats of substitution
3.4.1.4 Threats from new entrants
3.4.1.5 Competitive rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political landscape
3.4.2.2 Economic and Social landscape
3.4.2.3 Technology landscape
3.4.2.4 Legal landscape
3.4.2.5 Environmental landscape
3.5 Major Deals & Strategic Alliances Analysis
3.5.1 Joint Ventures
3.5.2 Mergers & Acquisitions
3.5.3 Licensing & Partnership
3.5.4 Technology Collaborations
3.6 Impact of COVID-19 Pandemic on Oncology Information Systems Market
Chapter 4 Oncology Information Systems Market: Products & Services Estimates & Trend Analysis
4.1 Definitions & Scope
4.2 Global Oncology Information Systems Market: Products & Services Market Share Analysis, 2020 and 2030
4.3 Solutions
4.3.1 Solutions analysis market estimates and forecasts, 2021 - 2033
4.3.2 Patient Information Systems
4.3.2.1 Patient information systems analysis market estimates and forecasts, 2021 - 2033
4.3.3 Treatment Planning System
4.3.3.1 Treatment planning system analysis market estimates and forecasts, 2021 - 2033
4.4 Professional Services
4.4.1 Professional services analysis market estimates and forecasts, 2021 - 2033
Chapter 5 Oncology Information Systems Market: Application, Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Global Oncology Information Systems Market: Application, Market Share Analysis, 2020 and 2030
5.3 Medical Oncology
5.3.1 Medical oncology analysis market estimates and forecasts, 2021 - 2033
5.4 Radiation Oncology
5.4.1 Radiation oncology analysis market estimates and forecasts, 2021 - 2033
5.5 Surgical Oncology
5.5.1 Surgical oncology analysis market estimates and forecasts, 2021 - 2033
Chapter 6 Oncology Information Systems Market: End User, Estimates & Trend Analysis
6.1 Definitions & Scope
6.2 Global Oncology Information Systems Market: End User, Market Share Analysis, 2020 and 2030
6.3 Hospitals & Diagnostic Imaging Centers
6.3.1 Hospitals & diagnostic imaging centers analysis market estimates and forecasts, 2021 - 2033
6.4 Ablation Care Centers & Cancer Care Centers
6.4.1 Ablation care centers & cancer care centers analysis market estimates and forecasts, 2021 - 2033
6.5 Government Institutions
6.5.1 Government Institutions analysis market estimates and forecasts, 2021 - 2033
6.6 Research Facilities
6.6.1 Research Facilities analysis market estimates and forecasts, 2021 - 2033
Chapter 7 Oncology Information Systems Market: Regional Estimates & Trend Analysis, By Product, application and end user
7.1 Global Oncology Information Systems Market: Regional Movement Analysis
7.2 North America
7.2.1 North America oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.2.2 U.S.
7.2.2.1 U.S. oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.2.3 Canada
7.2.3.1 Canada oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.3 Europe
7.3.1 Europe oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.3.2 U.K.
7.3.2.1 U.K. oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.3.3 Germany
7.3.3.1 Germany oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.3.4 France
7.3.4.1 France oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.3.5 Italy
7.3.5.1 Italy oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.3.6 Spain
7.3.6.1 Spain oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.4 Asia Pacific
7.4.1 Asia pacific oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.4.2 Japan
7.4.2.1 Japan oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.4.3 China
7.4.3.1 China oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.4.4 India
7.4.4.1 India oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.4.5 Thailand
7.4.5.1 Thailand oncology information systems market estimates and forecasts by product and services, and application, 2021 - 2033
7.4.6 South Korea
7.4.6.1 South Korea oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.5 Latin America
7.5.1 Latin America oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.5.2 Brazil
7.5.2.1 Brazil oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.5.3 Mexico
7.5.3.1 Mexico oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.5.4 Argentina
7.5.4.1 Argentina oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.5.5 Colombia
7.5.5.1 Colombia oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.6 MEA
7.6.1 MEA oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.6.2 Saudi Arabia
7.6.2.1 Saudi Arabia oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.6.3 South Africa
7.6.3.1 South Africa oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
7.6.4 UAE
7.6.4.1 UAE oncology information systems market estimates and forecasts by product and services, application and end user, 2021 - 2033
Chapter 8 Competitive Analysis
8.1 Recent Developments & Impact Analysis, By Key Market Participants
8.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
8.3 Key Company Market Share Analysis, 2021
8.4 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
8.5 List of Key Emerging Companies /Technology Disruptors/Innovators
Chapter 9 Company Profiles
9.1 Elekta AB
9.1.1 Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 Varian Medical Systems
9.2.1 Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.3 Accuray Incorporated
9.3.1 Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.4 Cerner Corporation
9.4.1 Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.5 RaySearch Laboratories
9.5.1 Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.6 Flatiron
9.6.1 Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.7 BrainLab
9.7.1 Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.8 Philips Healthcare
9.8.1 Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.9 Prowess, Inc.
9.9.1 Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.10 DOSIsoft S.A.
9.10.1 Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.11 ViewRay Inc.
9.11.1 Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.12 MIM Software
9.12.1 Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.13 McKesson Corporation
9.13.1 Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.14 Siemens Healthineers
9.14.1 Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers